top of page
Dr. Jim Melton on the BackTable VI Podcast

Dr. Jim Melton

Vascular Surgeon

5 Podcasts on BackTable

Dr. Jim Melton is a practicing Vascular Surgery Specialist in Oklahoma City.

Learn from the experiences and expertise of Dr. Jim Melton and other leading voices in your specialty on the BackTable app.

Intravascular Lithotripsy for Fem-Pop Disease in the ASC
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 310  •  10 Apr 2023

Intravascular Lithotripsy for Fem-Pop Disease in the ASC

In this episode, host Dr. Aaron Fritts interviews Dr. Jim Melton and Amanda Stanley about intravascular lithotripsy in the ASC, including reimbursement trends, patient selection and the future of the device.

This podcast is supported by

Shockwave Medical

More from Dr. Jim Melton

Loading recent podcasts…

About

Dr. Jim Melton is originally from Anadarko, Oklahoma, and has been in practice for 25 years. He earned his Doctorate of Osteopathy at the Oklahoma State University College of Osteopathic Medicine. He performed his Residency in General Surgery and his Fellowship in Peripheral Vascular Surgery at Doctors Hospital in Columbus, Ohio.

He is Board Certified in General and Vascular Surgery and has been instrumental in the advancement of vascular surgery and the treatment of peripheral artery disease in the state of Oklahoma throughout his career. He is co-founder of CardioVascular Health Clinic, Advanced CardioVascular Solutions, and Advanced Surgical and Research Solutions.

Visit CardioVascular Health Clinic to learn more about Dr. Jim Melton.

Dr. Melton and Amanda Stanley are paid consultants of Shockwave Medical. Opinions expressed are those of the speakers and not necessarily those of Shockwave Medical.

In the United States: Rx only.

Indications for Use—The Shockwave Medical Intravascular Lithotripsy (IVL) System is intended for lithotripsy-enhanced balloon dilatation of lesions, including calcified lesions, in the peripheral vasculature, including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries. Not for use in the coronary, carotid or cerebral vasculature.

Contraindications—Do not use if unable to pass 0.014″ (M5, M5+, S4, E8) or 0.018″ (L6) guidewire across the lesion-Not intended for treatment of in-stent restenosis or in coronary, carotid, or cerebrovascular arteries.

Warnings—Only to be used by physicians who are familiar with interventional vascular procedures—Physicians must be trained prior to use of the device—Use the generator in accordance with recommended settings as stated in the Operator’s Manual.

Precautions—use only the recommended balloon inflation medium—Appropriate anticoagulant therapy should be administered by the physician—Decision regarding use of distal protection should be made based on physician assessment of treatment lesion morphology.

Adverse effects–Possible adverse effects consistent with standard angioplasty include–Access site complications–Allergy to contrast or blood thinner–Arterial bypass surgery—Bleeding complications—Death—Fracture of guidewire or device—Hypertension/Hypotension—Infection/sepsis—Placement of a stent—renal failure—Shock/pulmonary edema—target vessel stenosis or occlusion—Vascular complications. Risks unique to the device and its use—Allergy to catheter material(s)— Device malfunction or failure—Excess heat at target site.

Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events. www.shockwavemedical.com/ifu

Please contact your local Shockwave representative for specific country availability.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page